Hypoxia-inducible Factor 2 alpha Inhibitors [MoA] - N0000193998
Pharmacologic Class Information
| Pharmacologic Code | N0000193998 |
| Pharmacologic Name | Hypoxia-inducible Factor 2 alpha Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Hypoxia-inducible Factor 2 alpha Inhibitors
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Hypoxia-inducible Factor 2 alpha Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0006-5331 | Welireg | Non-Proprietary Name: Belzutifan | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE |